Skip to Content

T 150 (Tarceva 150 mg)

Generic Name: erlotinib

This pill with imprint "T 150" is White, Round and has been identified as Tarceva 150 mg. It is supplied by Genentech.

Tarceva is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tarceva

Generic Name:
erlotinib
Imprint:
T 150
Strength:
150 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
EGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Genentech

Imprint Code FAQ's

Other Labelers / Repackagers:
NDC CodeLabeler / Repackager
54868-5447 Physicians Total Care Inc (repackager)
54569-5848 A-S Medication Solutions, LLC (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide